Computational and machine learning approaches to improve design and screening of peptides in drug discovery

Challenge: Protein-protein interactions (PPI) are well recognized as promising therapeutic targets. Although interfering peptides capable of inhibiting PPIs are receiving increased attention, the identification of those that possess high biological activity is very challenging due to their enormous diversity. There is thus a need to use bioinformatics and machine learning to effectively predict if a…

Detection of Molecular Interaction Field Similarities for the Rational Drug Design of Multi-Functional Inhibitors

Challenge: Binding promiscuity plays a major role in medicine as promiscuous drug interactions may lead to undesirable cross-reactivity effects. This represents a considerable challenge for the pharmaceutical industry. Drugs act by modulating the function of target proteins. However, additional off-site non-target proteins may also be affected due to similarities between binding sites. This unintentional effect…

Development of a machine learning-based in-process quality monitoring technology for plants during vaccine manufacturing

Challenge: Biological systems are often difficult to implement and maintain in an industrial setting. There is a large number of parameters to optimize and the complexity is great. Artificial intelligence (AI) can assist in uncovering patterns and identifying features among parameters that can improve the effectiveness of a process as well as the requirement for…

We are looking for the winning formula: job offer! ACCOUNTING TECHNICIAN

ABOUT CQDM Since its inception, CQDM has raised more than $275 million to fund the development of 150 + drugs addressing major health challenges, including cancer, neurodegenerative and metabolic diseases. CQDM is a biopharmaceutical research consortium whose mission is to fund the development of innovative tools and technologies that accelerate the development of safe and…

We are looking for the winning formula: job offer! ADMINISTRATIVE ASSISTANT

We are looking for the winning formula: job offer! FINANCIAL CONTROLLER

CQDM Announces the Arrival of Carl Baillargeon in its Team

MONTRÉAL, 15 June, 2023 – CQDM – biopharmaceutical research consortium – is proud to announce the arrival of Carl Baillargeon within its team as Chief communications and marketing officer. Carl Baillargeon is well known for his role as an Ambassador for life sciences, health technologies and innovation. For the past 20 years, he has consolidated…

Neomabs Biotechnologies, a company dedicated to developing new immunotherapies for cancer treatment launches in Montreal

MONTRÉAL, June 7, 2023 – Developing new generations of immunotherapies to treat currently incurable pediatric leukemia is the mission of Neomabs Biotechnologies, a new Montreal-based biotechnology company specializing in the discovery and development of innovative oncology therapies. The creation of Neomabs, the result of a strategic and innovative partnership between key players in the life…

Merck Canada reaffirms its commitment to CQDM with $3M in funding to support biopharmaceutical innovation.

Boston, Massachusetts – June 5, 2023 – CQDM is delighted, at BIO2023, in the presence of Minister Fitzgibbon, Quebec’s Minister of the Economy, Innovation and Energy (MEIE) to announce that Merck Canada, has renewed its commitment to CQDM with $3.0M in funding to support the development of innovative technologies in biopharmaceutical research. The innovative research and…

CQDM Funds Four Projects to Transform Innovation Into Promising Medical Solutions

BOSTON, June 5, 2023 – Pierre Fitzgibbon, Quebec Minister of the Economy, Innovation and Energy, Minister responsible for Regional Economic Development and Minister responsible for the Metropolis and the Montreal Region, today announced financial assistance totalling nearly $1.96 million for four biopharmaceutical R&D projects under CQDM’s SynergiQc program. CQDM is proud to contribute to the…

Category: Our News